Pharmaceutical composition comprising a GLP-1 agonist, an insulin, and methionine

摘要

The invention relates to a liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and optionally at least one pharmaceutically acceptable adjuvant, the composition being characterised in that it contains methionine, optionally as add-on therapy with metformin.